Basics Organogenesis Holdings Inc. IPO Date: January 2, 2017 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $634.29M Activated in VL: True Average Daily Range Avg Daily Range: $0.31 | 3.63% Avg Daily Range (30 D): $0.14 | 3.07% Avg Daily Range (90 D): $0.13 | 3.28% Institutional Daily Volume Avg Daily Volume: .59M Avg Daily Volume (30 D): .58M Avg Daily Volume (90 D): .89M Trade Size Avg Trade Size (Sh.): 116 Avg Trade Size (Sh.) (30 D): 104 Avg Trade Size (Sh.) (90 D): 119 Institutional Trades Total Inst.Trades: 834 Avg Inst. Trade: $2.33M Avg Inst. Trade (30 D): $2.15M Avg Inst. Trade (90 D): $1.47M Avg Inst. Trade Volume: .36M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.14M Avg Closing Trade (30 D): $.77M Avg Closing Trade (90 D): $.98M Avg Closing Volume: 264.94K     News Jul 30, 2025 @ 5:00 PM Global Amniotic Membrane Market Poised for Extraor... Source: Delveinsight Feb 28, 2025 @ 5:45 AM Organogenesis (ORGO) Q4 2024 Earnings Call Transcr... Source: The Motley Fool Jun 6, 2024 @ 8:05 PM Organogenesis Holdings Inc. to Participate in theÃ... Source: Organogenesis Holdings Inc. May 10, 2024 @ 12:45 AM Organogenesis (ORGO) Q1 2024 Earnings Call Transcr... Source: newsfeedback@fool.com (Motley Fool Transcribing) Apr 16, 2024 @ 11:30 AM Organogenesis Holdings Inc. to Report First Quarte... Source: Organogenesis Holdings Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.1 $-.17 Diluted EPS $-.1 $-.17 Revenue $ $ 101.01M $ 86.69M Gross Profit $ $ $ 62.97M Net Income / Loss $ $ -9.39M $ -18.84M Operating Income / Loss $ $ -12.58M $ -26.75M Cost of Revenue $ $ $ 23.72M Net Cash Flow $ $ -36.8M $ -25.62M PE Ratio